Key Takeaways
- IBM issued a rare preliminary Q2 announcement showing revenue of $17.2 billion, significantly below the $17.9 billion Wall Street forecast
- The company’s adjusted earnings per share of $2.93 fell short of the $3.01 analyst projection
- On July 14, IBM shares plummeted 25% in their largest single-session decline in company history, with weekly losses reaching 26%
- Arvind Krishna, IBM’s chief executive, attributed the shortfall to customers redirecting spending toward AI hardware and multiple major contracts missing closing deadlines
- Market expectations suggest approximately 7% volatility following Wednesday’s comprehensive earnings disclosure
IBM delivers its comprehensive second-quarter financial results Wednesday after market close. While the headline figures are already public, market participants are focused on forward guidance and strategic direction.
International Business Machines Corporation, IBM
The company shocked markets earlier in July with a pre-earnings announcement revealing significant misses on both top and bottom lines. This marked just the second instance in IBM’s lengthy corporate history of such a warning—the previous occasion occurred during the 2008-2009 financial meltdown.
The preliminary second-quarter figures showed total revenue reaching $17.2 billion, approximately $660 million beneath analyst projections of $17.9 billion. On the profitability front, adjusted earnings per share landed at $2.93 versus the Street’s $3.01 expectation.
Segment performance painted a mixed picture: infrastructure revenues declined 7% compared to the prior year, consulting remained stagnant, while software managed modest 5% expansion.
Market reaction was swift and brutal. IBM shares collapsed 25% on July 14, marking the company’s steepest one-day percentage loss ever and erasing approximately $70 billion in shareholder value. Over the complete trading week, the decline reached 26%—establishing IBM’s worst-ever five-day performance.
Chief Executive Arvind Krishna attributed the miss to clients aggressively reallocating capital expenditures toward servers, memory modules, and related infrastructure components amid supply constraints and anticipated cost increases.
“We did not anticipate the magnitude of the capex reprioritization,” Krishna explained in his shareholder correspondence.
Krishna further highlighted that “numerous large deals” experienced closing delays beyond anticipated timeframes, accounting for the bulk of the quarterly performance gap.
Analyst Focus for Wednesday’s Call
Given the preliminary disclosure, Wednesday’s earnings presentation centers less on historical performance and more on future trajectory. The investment community seeks confirmation that Q2’s delayed transactions have materialized in Q3, and whether IBM can still achieve its annual objectives: exceeding 5% constant-currency revenue expansion and delivering roughly $1 billion in free cash flow improvement.
Mizuho analyst Dan O’Regan indicated to Barron’s that IBM must demonstrate sustained customer demand, validate its artificial intelligence and software growth thesis, and articulate a convincing path forward.
O’Regan acknowledged the selloff contained merit considering IBM’s elevated valuation entering 2025, though he suggested the market potentially underweighted positive developments in software and AI divisions. “If those trends remain intact, investors may ultimately view this as an execution reset rather than a deterioration of the long-term story,” O’Regan noted.
Skeptics Saw Warning Signs
Bearish analysts weren’t caught off guard. BNP Paribas’ Stefan Slowinski had consistently raised valuation concerns. “Investors are overpaying for very low organic growth,” he explained to Barron’s, highlighting IBM’s dependence on acquisitive growth rather than internal expansion.
Slowinski’s Wednesday priority centers on cash generation. “Even if they do take down their full-year revenue guidance, can they keep their full-year cashflow guidance?” he questioned.
Notwithstanding numerous price target reductions following the warning, IBM maintains an Overweight consensus rating according to FactSet data. Jefferies maintained its Buy recommendation Tuesday while reducing its price objective to $260 from $320.
IBM previously announced $12.5 billion in generative artificial intelligence contract bookings. Market participants will scrutinize updates regarding Red Hat performance, watsonx platform adoption, and the comprehensive AI opportunity pipeline during Wednesday’s discussion.
Current options market pricing indicates an anticipated price movement of approximately 7% following the earnings release.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
